Direct Thrombin Inhibitor for LVAD Thrombosis: A Closer Look
Review published in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2016)
Abstract
Available options for the treatment of advanced heart failure have expanded to include the use of mechanical circulatory assist devices to improve quality of life in those both eligible and ineligible for heart transplant. Although there have been significant advancements in device technologies, anticoagulation protocols, and multidisciplinary team management, bleeding and thrombosis are the most common adverse effects. Management strategies for pump thrombosis and their outcomes vary considerably among mechanical circulatory support centers and include intensification of antithrombotic therapy (medical) and device exchange (surgical). We describe a successful case of medical therapy for pump thrombosis with bivalirudin monotherapy.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Available options for the treatment of advanced heart failure have expanded to include the use of mechanical circulatory assist devices to improve quality of life in those both eligible and ineligible for heart transplant.
Por qué esto importa para la hirudoterapia
This article discusses the management of bleeding and thrombosis in patients with mechanical circulatory assist devices for advanced heart failure, noting that strategies for pump thrombosis vary among centers and include intensification of antithrombotic therapy (medical) and device exchange (surgical). The authors describe a successful case of medical therapy for pump thrombosis using bivalirudin monotherapy. The abstract makes no mention of hirudin, leeches, direct thrombin inhibition, leech-derived components, or hirudotherapy. Accordingly, no defensible connection to ASH's domain or the leech secretome can be drawn from this source alone; any relationship between bivalirudin and leech-derived anticoagulants would require external information not present in the abstract.
Citación
Direct Thrombin Inhibitor for LVAD Thrombosis: A Closer Look
Rimsans J et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2016
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026